The company reported performance changes that led to the product recall and said it is pursuing eventual FDA clearance for the devices.
An international group of researchers aim to develop an approach that may be able to diagnose multiple conditions, including pneumonia, tuberculosis, sepsis, with one blood sample.
The team anticipates launching its first clinical diagnostic assay, which will detect targeted, low-frequency genetic mutations in lung cancer, in 2021.
The diagnostic firms were the final companies in the coverage universe of 360Dx to present at the annual conference.
The immune sequencing firm announced preliminary full-year 2019 revenues in the range of $84 million to $85 million, an increase of approximately 52 percent.
The funds will support the companies' efforts to develop tests for predicting NSCLC patients' response to immunotherapy.
Ravitej Reddy pleaded guilty in federal court to allegations he illegally billed Medicare for cancer genomic testing and pharmacogenetic testing.